Page 8 - Journal of Special Operations Medicine - Winter 2016

Executive Summary
improved blood products and damage control resuscitation
The United States (U.S.) Combat Casualty Care Research approaches.
Program (CCCRP) at the U.S. Army Medical Research and The Forward Surgical and Intensive Critical Care Portfolio
Materiel Command (USAMRMC) is a requirements-driven
medical research and development (R&D) program that is chapter highlights five successes, illustrating advances that
both directly improve prehospital survival and provide en-
developing knowledge and materiel solutions for the man-
agement of combat-related trauma. Through these solu- abling capabilities for medical providers including decision
support, monitoring, and triage tools.
tions, the CCCRP seeks to optimize survival and recovery
from combat injury in current and future operations. The Joint En Route Care Portfolio chapter highlights three
successes in the areas of preparing patients for transport with
Successful products and capabilities that have resulted from
R&D programmed and overseen by the CCCRP were iden- the use of advanced life support equipment, ensuring patient
safety during transport through implementation of new medi-
tified and characterized to illustrate progress toward the
goal of advancing and improving hemorrhage control and cal technology with associated provider training, and evaluat-
ing advanced patient monitoring equipment for en route use.
resuscitation, forward surgical and intensive critical care,
casualty transport, and care for traumatic brain injury (TBI) The Neurotrauma Portfolio chapter highlights five successes
and other neurological trauma. The highlighted successes that are advancing multiple products that may be used to ef-
demonstrate how the work within the CCCRP’s portfolios fectively diagnose and treat TBI for the warfighter.
has directly impacted the warfighter and contributed to
the closure of capability gaps defined by key requirements Though the successes highlighted represent only a fraction of
sources, including the 2008 Guidance for Development of the achievements and ongoing efforts of these CCCRP port-
the Force Assessment, the 2006 Army Theater Combat Ca- folios, they provide concrete illustrations of the impacts of
sualty Care Initial Capabilities Document (ICD), and the the CCCRP requirements-driven R&D investments for the
2015 Defense Health Program Combat Casualty Care ICD. warfighter on the battlefield. These successes are character-
ized with respect to the capability gaps they have addressed,
The Hemorrhage and Resuscitation Portfolio chapter high- CPGs they have influenced, and the peer-reviewed publica-
lights seven successes focused on the development of new tions that have provided the foundation for these changes.
products and advancement of key clinical practice guide-
lines (CPGs). These include the stories of bringing new From: https://ccc.amedd.army.mil/ScientificPapers/2015%20
Combat%20Casualty%20Care%20Research%20Program%20
hemostatic devices to the battlefield, as well as advancing Capability%20Gap%20Closure%20Analysis.pdf

vi